The winners of the Lambertine Lacroix Prize 2024 - Cardiovascular Diseases were honoured on Friday 9 February at the annual congress of the Belgian Society of Cardiology (BSC). The Lambertine Lacroix Prize for Cardiovascular Diseases is being awarded this year for the 7th time in its history. Following a call for applications in the summer of 2023, a five-member international jury met on 23 November to assess the applications submitted by researchers from the Wallonia-Brussels Federation under the age of 51. Given the very high standard of applications for the Prize, the Foundation's Board of Directors has exceptionally decided to award two Prizes this year.

The 2024 laureates are :

• Ms Laure Elens, Professor at UCLouvain and Promoter of a PDR-FNRS, for her work entitled "Importance of pharmacokinetics and individual factors to explain variability in Atorvastatin clinical response". Interview
• Mr Benoit Vanhollebeke, Professor at ULB, for his work entitled "Blood-brain barrier: from molecular mechanisms to intervention strategies". Interview

The Lambertine Lacroix Foundation

The Lambertine Lacroix Foundation was created in 2006 in accordance with the will of her daughter Jenny Dupont. Jenny Dupont, whose life had been severely handicapped by serious heart damage, had made many personal sacrifices in order to raise a capital sum which, on her death, would serve as the basis for the creation of a Foundation whose aim would be to reward research into the diseases that had been fatal to her mother and herself, namely cancer and cardiovascular disease.

The Prize

The Prize of the Lambertine Lacroix Foundation, whose Board of Directors delegates the management of calls for proposals to the FNRS, is awarded every two years and rewards research into cardiovascular disease and cancer, alternately.
The prize is worth €30,000, half of which is awarded to the winner in recognition of research already carried out, and the other half to the winner's laboratory in support of future research.